382 related articles for article (PubMed ID: 22452596)
1. Short bowel syndrome in children: current and potential therapies.
Uko V; Radhakrishnan K; Alkhouri N
Paediatr Drugs; 2012 Jun; 14(3):179-88. PubMed ID: 22452596
[TBL] [Abstract][Full Text] [Related]
2. Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation.
Martin GR; Beck PL; Sigalet DL
World J Gastroenterol; 2006 Jul; 12(26):4117-29. PubMed ID: 16830359
[TBL] [Abstract][Full Text] [Related]
3. Experience with teduglutide treatment for short bowel syndrome in clinical practice.
Pevny S; Maasberg S; Rieger A; Karber M; Blüthner E; Knappe-Drzikova B; Thurmann D; Büttner J; Weylandt KH; Wiedenmann B; Müller VA; Bläker H; Pascher A; Pape UF
Clin Nutr; 2019 Aug; 38(4):1745-1755. PubMed ID: 30145039
[TBL] [Abstract][Full Text] [Related]
4. Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study.
Jeppesen PB; Pertkiewicz M; Forbes A; Pironi L; Gabe SM; Joly F; Messing B; Loth S; Youssef NN; Heinze H; Berghöfer P
Clin Nutr; 2013 Oct; 32(5):713-21. PubMed ID: 23587733
[TBL] [Abstract][Full Text] [Related]
5. Understanding short bowel syndrome: Current status and future perspectives.
Massironi S; Cavalcoli F; Rausa E; Invernizzi P; Braga M; Vecchi M
Dig Liver Dis; 2020 Mar; 52(3):253-261. PubMed ID: 31892505
[TBL] [Abstract][Full Text] [Related]
6. Teduglutide for pediatric short bowel syndrome patients.
Rosete BE; Wendel D; Horslen SP
Expert Rev Gastroenterol Hepatol; 2021 Jul; 15(7):727-733. PubMed ID: 33798402
[No Abstract] [Full Text] [Related]
7. Current treatment paradigms in pediatric short bowel syndrome.
Chandra R; Kesavan A
Clin J Gastroenterol; 2018 Apr; 11(2):103-112. PubMed ID: 29280097
[TBL] [Abstract][Full Text] [Related]
8. Anatomical and physiological considerations in short bowel syndrome: Emphasis on intestinal adaptation and the role of enterohormones.
Tappenden KA
Nutr Clin Pract; 2023 May; 38 Suppl 1():S27-S34. PubMed ID: 37115026
[TBL] [Abstract][Full Text] [Related]
9. Acute effects of the glucagon-like peptide 2 analogue, teduglutide, on intestinal adaptation in short bowel syndrome.
Thymann T; Stoll B; Mecklenburg L; Burrin DG; Vegge A; Qvist N; Eriksen T; Jeppesen PB; Sangild PT
J Pediatr Gastroenterol Nutr; 2014 Jun; 58(6):694-702. PubMed ID: 24399211
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic options for intestinal rehabilitation in patients with short bowel syndrome.
Jeppesen PB
JPEN J Parenter Enteral Nutr; 2014 May; 38(1 Suppl):45S-52S. PubMed ID: 24615689
[TBL] [Abstract][Full Text] [Related]
11. Modern treatment of short bowel syndrome.
Jeppesen PB
Curr Opin Clin Nutr Metab Care; 2013 Sep; 16(5):582-7. PubMed ID: 23924950
[TBL] [Abstract][Full Text] [Related]
12. Medical and surgical management of short bowel syndrome.
Billiauws L; Maggiori L; Joly F; Panis Y
J Visc Surg; 2018 Sep; 155(4):283-291. PubMed ID: 30041905
[TBL] [Abstract][Full Text] [Related]
13. Differential Effects on Intestinal Adaptation Following Exogenous Glucagon-Like Peptide 2 Therapy With and Without Enteral Nutrition in Neonatal Short Bowel Syndrome [Formula: see text].
Lim DW; Diané A; Muto M; Vine DF; Nation PN; Wizzard PR; Sigalet DL; Bigam DL; Pencharz PB; Turner JM; Wales PW
JPEN J Parenter Enteral Nutr; 2017 Feb; 41(2):156-170. PubMed ID: 27660290
[TBL] [Abstract][Full Text] [Related]
14. Intestinal adaptation following resection.
Tappenden KA
JPEN J Parenter Enteral Nutr; 2014 May; 38(1 Suppl):23S-31S. PubMed ID: 24586019
[TBL] [Abstract][Full Text] [Related]
15. Predictors of Intestinal Adaptation in Children.
Venick RS
Gastroenterol Clin North Am; 2019 Dec; 48(4):499-511. PubMed ID: 31668179
[TBL] [Abstract][Full Text] [Related]
16. What's new in short bowel syndrome?
Billiauws L; Corcos O; Joly F
Curr Opin Clin Nutr Metab Care; 2018 Jul; 21(4):313-318. PubMed ID: 29702489
[TBL] [Abstract][Full Text] [Related]
17. Medical update and potential advances in the treatment of pediatric intestinal failure.
Youssef NN; Mezoff AG; Carter BA; Cole CR
Curr Gastroenterol Rep; 2012 Jun; 14(3):243-52. PubMed ID: 22528662
[TBL] [Abstract][Full Text] [Related]
18. An updated overview of glucagon-like peptide-2 analog trophic therapy for short bowel syndrome in adults.
Zhu C; Li Y
J Int Med Res; 2022 Mar; 50(3):3000605221086145. PubMed ID: 35343263
[TBL] [Abstract][Full Text] [Related]
19. Emerging treatments for short bowel syndrome in adult patients.
Billiauws L; Joly F
Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):241-246. PubMed ID: 30791759
[TBL] [Abstract][Full Text] [Related]
20. Small-Bowel Adaptation: A Case of Morphological Changes Induced by Teduglutide in Short-Bowel Syndrome With Intestinal Failure.
Mouillot T; Boehm V; Treton X; Ferrandi E; Kapel N; Cazals-Hatem D; Joly F
JPEN J Parenter Enteral Nutr; 2020 Jul; 44(5):940-943. PubMed ID: 32187383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
